- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03963804
Objective Brain Function Assessment of mTBI/Concussion (CAS13-25)
May 22, 2019 updated by: BrainScope Company, Inc.
Objective Brain Function Assessment of mTBI From Initial Injury to Rehabilitation in Concussion
This study (Part 3) is designed to build a database including EEG, neurocognitive performance, clinical symptoms, history and other relevant data, which will be used to derive a multimodal EEG based algorithm for the identification of concussion and tracking of recovery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Injured/concussed subjects will be studied at time of injury, and at 3 follow-up time points following injury.
Subjects will come from the sports and other populations of concussed individuals.
They will be matched with controls i.e. not head injured subjects who will also undergo the same set of tests and the same time intervals as the injured subjects.
An additional pool of uninjured (not head injured) subjects will be collected who will be assessed at a single time point.
This data will be used to populate a database for the purpose of deriving a multimodal concussion index.
Study Type
Observational
Enrollment (Actual)
268
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arkansas
-
Fayetteville, Arkansas, United States, 72701
- University of Arkansas
-
-
Florida
-
Miami, Florida, United States, 33136
- University of Miami
-
-
Michigan
-
East Lansing, Michigan, United States, 48824
- Michigan State University
-
-
New York
-
Rochester, New York, United States, 14642
- University of Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 25 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Approximately 490 Injured, Matched Control and Healthy Volunteer subjects will be recruited from high schools, college universities, concussion clinics and emergency rooms.
Description
Inclusion Criteria:
For Injured subjects:
- Having sustained a traumatic closed head injury within 72 hours (3 days) from time of injury at time of BrainScope assessment;
- GCS 13-15 at time of BrainScope assessment;
- No hospital admission due to either head injury or collateral injuries for >24 hours.
For Matched Controls:
- GCS 15 at time of BrainScope assessment;
- No prior history of concussion or TBI in the last year.
Exclusion Criteria:
- Previously enrolled in the BrainScope CAS Studies;
- Current CNS active prescription medications taken daily, with the exception of medications being taken for the treatment of Attention Deficit Disorder (ADD) or Attention Deficit Hyperactivity Disorder (ADHD);
- Forehead, scalp or skull abnormalities that prevents headset application or EEG data collection;
- History of brain surgery or neurological disease;
- Pregnant women;
- Subjects who do not speak English (non-English speaking parents are allowed to consent so long as translation of the consent form in their native language is available);
- Acute intoxication;
- Evidence of illicit drug usage;
For Injured subjects:
- Loss of consciousness ≥ 20 minutes related to the concussion injury;
- Active fever defined as greater than 100ºF or 37.78ºC at time of BrainScope assessment;
- Evidence of abnormality visible on Computerized Tomography (CT) of the head related to the traumatic event (Note: neuroimaging is not required for enrollment).
For Matched Controls:
- Any focal neurological signs including aphasia, apraxia, diplopia, facial droop, dysarthria/slurred speech;
- History of Motor Vehicle Accident (MVA) requiring an Emergency Department visit within the past 1 year.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Injured and Matched Control Subject Pool
Injured subjects consist of subjects who are head injured and meet the inclusion/exclusion criteria.
Injured subjects will be tested within 72 hours (3 days) of injury and at specified time points post injury.
Matched control subjects will be tested at the same time intervals as the injured subject.
BrainScope Battery will be performed at each time point and consists of the following components: brain electrical activity (EEG), neurocognitive performance assessment, ocular motor assessment, and clinical symptoms/assessments.
|
The BrainScope Battery evaluation will consist of 4 tests to aid in the assessment of concussion: History, Physical, signs and symptoms (SAC, SCAT5), Electrophysiological Function; Neurocognitive Performance Assessment and Ocular Motor Assessment.
BrainScope Ahead 300iP will be used to perform EEG and Cognitive assessments.
|
Healthy Volunteer Subject Pool
This subject pool will consist of uninjured (not head injured) subjects and will be tested at a single time point.
These subjects will perform the same BrainScope Battery as the injured and matched control subjects.
|
The BrainScope Battery evaluation will consist of 4 tests to aid in the assessment of concussion: History, Physical, signs and symptoms (SAC, SCAT5), Electrophysiological Function; Neurocognitive Performance Assessment and Ocular Motor Assessment.
BrainScope Ahead 300iP will be used to perform EEG and Cognitive assessments.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Derivation of algorithm for Likelihood of being concussed using multimodal inputs
Time Frame: 6 months for data acquisition, with each patient studied from time of injury to 45 days after RTP
|
Create a database of all assessments including brain electrical activity (EEG features including all frequency bands and measures (power, connectivity,complexity), neurocognitive performance tests scores (throughput measures), balance, and clinical/symptom assessments (SCAT5), to support derivation of a multimodal brain function/concussion index.
(NOTE: All EEG and Neurocognitive features are expressed as z-scores relative to age expected normal values to enable combination)
|
6 months for data acquisition, with each patient studied from time of injury to 45 days after RTP
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 11, 2018
Primary Completion (Actual)
January 25, 2019
Study Completion (Actual)
March 29, 2019
Study Registration Dates
First Submitted
May 21, 2019
First Submitted That Met QC Criteria
May 22, 2019
First Posted (Actual)
May 28, 2019
Study Record Updates
Last Update Posted (Actual)
May 28, 2019
Last Update Submitted That Met QC Criteria
May 22, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 31-Ahead
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Injuries, Traumatic
-
Fondazione per la Ricerca Ospedale MaggioreCompletedBrain Injuries, Traumatic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateItaly
-
Hospital Sirio-LibanesUniversity of Sao Paulo; Ministry of Health, Brazil; Hospital Sao Rafael; PROAD... and other collaboratorsRecruitingBrain Injury Traumatic Severe | Brain Injury Traumatic Moderate | Post Traumatic EpilepsyBrazil
-
Technical University of MunichFederal Ministry of Defence (Germany); Bundesministerium der VerteidigungRecruitingTraumatic Brain InjuriesFrance, Germany
-
Eunice Kennedy Shriver National Institute of Child...CompletedTraumatic Brain Injuries
-
Children's Hospital Medical Center, CincinnatiUniversity of CincinnatiCompletedBrain Injury Traumatic MildUnited States
-
University of Alabama at BirminghamCompletedTraumatic Brain InjuriesUnited States
-
University of TurkuTurku University Hospital; The Finnish Funding Agency for Technology and Innovation... and other collaboratorsCompletedBrain Injuries | TBI (Traumatic Brain Injury) | Brain Injuries, Traumatic | Traumatic Brain Injury | Injury, Brain, TraumaticFinland
-
Toronto Rehabilitation InstituteCentre for Aging and Brain Health Innovation; Ontario Neurotrauma FoundationUnknownBrain Injuries, Traumatic | Brain Injury, Chronic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateCanada
-
Institut National de la Santé Et de la Recherche...Institut National de Recherche en Informatique et en AutomatiqueNot yet recruitingTBI (Traumatic Brain Injury)France
-
Allina Health SystemCompletedConcussion, Brain | Brain Injury Traumatic MildUnited States
Clinical Trials on BrainScope Ahead 300iP
-
BrainScope Company, Inc.CompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.United States Department of DefenseCompletedBrain Injuries | Concussion, Mild | Concussion, Brain | Concussion, Intermediate | Near Point ConvergenceUnited States
-
BrainScope Company, Inc.United States Department of DefenseCompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.CompletedBrain InjuriesUnited States
-
BrainScope Company, Inc.CompletedBrain InjuriesUnited States
-
BrainScope Company, Inc.United States Department of DefenseCompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.CompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
The University of Texas Health Science Center at...National Institute on Aging (NIA); The Claude D. Pepper Older Americans Independence...CompletedType 2 Diabetes | Frailty | Weight, BodyUnited States
-
Texas Tech University Health Sciences Center, El...BrainScope Company, Inc.RecruitingCOVID-19United States
-
Fox Chase Cancer CenterCompletedCancer of the Head and NeckUnited States